Lung Cancer Somatic Panel (30 Genes)

Definition

While the NCCN guideline recommends that EGFR, ALK, ROS1 and PD-L1 be tested at a minimum in NSCLC, the broader molecular profiling approach also requires evaluation of BRAF, ERBB2, KRAS, METex14 and NTRK1/2/3 and RET rearrangements. NGS panels make it possible to evaluate all of these genes at once.

Gene/region examined

FGFR2, BRAF, KRAS, NRAS, MET, CDK6, EGFR, SOD2, ESR1, ROS1, RICTOR, TERT, KIT, PDGFRA, PIK3CA, MYD88, ERBB4, IDH1, IDH2, ALK, STK11, ERBB2, TP53, MAP2K1, AKT1, CDK4, GAPDH, PTEN, DDR2, NTRK1

Method

Next Generation Sequencing

Accepted sample types

Solid Tumor-FFPE

Inheritance

Entirely somatic (acquired in tumor tissue) mutation and fusion analysis; germline tissue is not evaluated.

Related Tests